ADTX - Aditxt Sales Growth YoY (TTM)

Public company logo of Aditxt Inc. (ADTX)

Aditxt specializes in immune reprogramming, utilizing the Pears platform for precise graft control. Meanwhile, management is adapting to high volatility and active mergers, which is eroding shareholder confidence. The LTM annual sales growth rate demonstrates business dynamics where the -74.20 level represents the current value. Its first-mover status in personalized medicine strengthens the brand's reputation.

aditxt.com (ADTX) - Sales Growth YoY (TTM) from 02/11/2024 to 07/11/2026

aditxt.com - analytical breakdowns and key metrics (ADTX)

- market value and analyst target forecast:
Market Price Aditxt Corp|ADTX - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Aditxt, Inc.|ADTX - Enterprise Value
- book value of equity indicators:
Equity per Share Aditxt|ADTX - Book Capitalization|Market Capitalization to Book Value aditxt.com|ADTX - Cumulative Company Assets
- business debt structure and liquidity details:
Aggregate Debt to Capital Aditxt|ADTX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Ratio aditxt.com|ADTX - Company Total Debt|Debt to Book Capital Aditxt, Inc.|ADTX - Company Long-Term Debts|Company Short-Term Debts Aditxt|Immediate Liquidity Ratio aditxt.com
- earnings and valuation multiples indicators:
ADTX - Net Income|Future Net Profit Aditxt|ADTX - Price to Earnings Ratio|Price to Future Earnings Ratio Aditxt|ADTX - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Aditxt, Inc.|ADTX - Operating profit EBITDA|Earnings per share for the trailing year Aditxt|ADTX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth aditxt.com|ADTX - Earnings per share growth in current year|Expected earnings per share trend next year Aditxt
- sales revenue and business income indicators:
ADTX - Company Revenue|Company Future Sales Volume Aditxt Corp|ADTX - P/S Multiple|Forward P/S Multiple Aditxt Corp|ADTX - Revenue Growth YoY (Last 12 Months)
Fundamental company valuation:aditxt.com ADTX
Product sample of Aditxt

This indicator filters out market noise by measuring the percentage growth rate of the rolling annual revenue to distinguish random spikes from a sustainable trend. The current value of -74.20 in comparable year-over-year sales growth over 12 months reflects the financial efficiency of scaling Aditxt (ADTX) autonomous AI platforms, AditxtScore, and robotic dispensers in clinical laboratories, confirming the actual commercialization of the company's technologies.

Who Aditxt competes with

Argenx (ARGX) - Trailing Twelve Months Revenue Growth|BioNTech SE - Sales Growth YoY (TTM)|ABVX - Sales Growth YoY (TTM)|ADMA: Sales Growth YoY (TTM)|Protagonist Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Immunovant Therapeutics|Sales Growth YoY (Last 12 Months) KNSA (Kiniksa Pharmaceuticals Ltd)|Sales Growth YoY (TTM) GRFS|ADPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) CLDX (Celldex)|AUPH: Sales Growth YoY (Last 12 Months)|BCRX: Revenue Growth YoY (Last 12 Months)|Vera Pharma - Revenue Change YoY (Last 12 Months)|DNTH (Dianthus Corp) - Revenue Growth YoY (Last 12 Months)|Pharvaris N.V. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) AbCellera Biologics|Tourmaline Bio Inc (TRML) - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) PGEN (Intrexon)|PHAR (Pharming) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) NKTR (Nektar Therapeutics Inc)|Annual Revenue Growth (Last Twelve Months) upstreambio.com (UPB)|Zenas Biopharma - Sales Growth YoY (TTM)|IMNM (Immunome) - Sales Growth YoY (Last 12 Months)|gossamerbio.com (GOSS) - Sales Growth YoY (Last Twelve Months)|KalVista Corp (KALV) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) septerna.com|Sales Growth YoY (TTM) Pieris Pharmaceuticals|Sales Growth YoY (Last Twelve Months) Savara (SVRA)|RIGL - Trailing Twelve Months Revenue Growth|AnaptysBio Inc. - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) Astria Therapeutics ATXS|ENGN: Revenue Growth YoY (Last 12 Months)|RAPT Therapeutics Inc. (RAPT) - Revenue Growth YoY (Last 12 Months)|JBIO (Aerovate Therapeutics) - Revenue Growth YoY (Last 12 Months)|ACRS: Revenue Change YoY (Last 12 Months)|KYTX (Kyverna Therapeutics, Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) TLSA (Tiziana Life Sciences PLC)|Sales Growth YoY (TTM) CABA|Sales Growth YoY (Last Twelve Months) VTYX (Ventyx Biosciences, Inc.)|Sales Growth YoY (Last Twelve Months) Theratechnologies Inc THTX|Annual Revenue Growth (Last Twelve Months) Avalo Therapeutics, Inc. (AVTX)|ELDN - Sales Growth YoY (Last Twelve Months)|AGEN - Sales Growth YoY (TTM)|climbbio.com (CLYM) - Sales Growth YoY (Last Twelve Months)|Zura Bio - Revenue Dynamics YoY (Last Twelve Months)|ATYR (atyrpharma.com) - Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) ADAG (Adagene)|Sales Growth YoY (TTM) IMA|STTK (Shattuck Labs) - Revenue Dynamics YoY (Last Twelve Months)|Equillium Inc - Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) CNTB|IMUX - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth ATRA|IFRX (InflaRx) - Revenue Growth YoY (Last 12 Months)|X4 Pharma (XFOR) - Sales Growth YoY (TTM)|ACET (Adicet) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) celularity.com (CELU)|Sales Growth YoY (Last Twelve Months) INmune Bio Inc (INMB)|Annual Revenue Growth (Last Twelve Months) Barinthus Biotherapeutics PLC|Sales Growth YoY (Last Twelve Months) Kezar Life Sciences Inc KZR|Revenue Dynamics YoY (Last Twelve Months) SABS|AKTX - Sales Growth YoY (Last Twelve Months)|Revenue Dynamics YoY (Last Twelve Months) ENLV (enlivex.com)|QTTB: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) GOVX|Revenue Growth YoY (Last 12 Months) EDSA|Sales Growth YoY (Last 12 Months) IBIO (iBio Corp)|Sales Growth YoY (Last Twelve Months) Carisma Therapeutics Inc (CARM)|Annual Revenue Growth (Last Twelve Months) xtlbio.com|Bolt Biotherapeutics Inc. - Revenue Growth YoY (Last 12 Months)|HCW Biologics Inc (HCWB) - Trailing Twelve Months Revenue Growth|Aptevo - Sales Growth YoY (TTM)|AIM ImmunoTech (AIM) - Revenue Growth YoY (Last 12 Months)|GRI Bio (GRI) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XORTX Therapeutics|Sales Growth YoY (Last Twelve Months) Vyome Therapeutics|Sales Growth YoY (Last 12 Months) REVB (Revelation Biosciences, Inc.)|Sales Growth YoY (TTM) INDP|Revenue Growth YoY (Last 12 Months) Scinai Immunotherapeutics SCNI|Sales Growth YoY (TTM) CALI (CalciMedica)|AFMD - Revenue Growth YoY (Last 12 Months)|ALLK: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) HOOKIPA Pharma HOOK|IGMS: Sales Growth YoY (TTM)|ITOS: Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Ocean Biomedical|tcbiopharm.com - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Third Harmonic Bio, Inc. (THRD)